Literature DB >> 19170584

Using secondary data sources for pharmacoepidemiology and outcomes research.

Spencer E Harpe1.   

Abstract

The increased availability of electronic medical records and administrative health care databases is adding to the popularity of pharmacoepidemiology and outcomes research studies. Despite their availability, practitioners may be reluctant to use these databases because they lack familiarity with database research in general. The basic principles of research are the same regardless of the data source, but there are a few special considerations. When using secondary data sources for research purposes, special care must be taken to select an appropriate source to ensure that relevant information is available to answer the research question at hand. Special attention must also be paid to selecting the appropriate codes to represent the outcomes and exposures of interest; therefore, a general understanding of coding schemes is necessary. Although time may be saved by not prospectively collecting data, the process of manipulating the data for analysis in secondary databases can be complex. Analysis of data from secondary sources may require special procedures to overcome the lack of randomization. By familiarizing themselves with these special issues, practitioners can use secondary sources to conduct studies that make valuable contributions to the improvement of patient care.

Entities:  

Mesh:

Year:  2009        PMID: 19170584     DOI: 10.1592/phco.29.2.138

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  22 in total

1.  Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.

Authors:  Alessandro Roggeri; Daniela Paola Roggeri; Carlo Zocchetti; Maurizio Bersani; Ferruccio Conte
Journal:  J Nephrol       Date:  2016-05-10       Impact factor: 3.902

2.  Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation.

Authors:  Sanjeev N Mehta; Allison B Goldfine; Martin J Abrahamson; Richard DiVincenzo; Lori M B Laffel
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

3.  An introduction to the fundamentals of cohort and case-control studies.

Authors:  John-Michael Gamble
Journal:  Can J Hosp Pharm       Date:  2014-09

4.  Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data.

Authors:  Renu K Garg; Nicole L Glazer; Kerri L Wiggins; Katherine M Newton; Evan L Thacker; Nicholas L Smith; David S Siscovick; Bruce M Psaty; Susan R Heckbert
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-12-23       Impact factor: 2.890

5.  Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting.

Authors:  Amy Peacock; Briony Larance; Raimondo Bruno; Sallie-Anne Pearson; Nicholas A Buckley; Michael Farrell; Louisa Degenhardt
Journal:  Addiction       Date:  2018-09-07       Impact factor: 6.526

6.  The intriguing future of pharmacoepidemiology.

Authors:  Björn Wettermark
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

Review 7.  Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sources.

Authors:  Marianne Meaidi; Henrik Støvring; Klaus Rostgaard; Christian Torp-Pedersen; Kristian Hay Kragholm; Morten Andersen; Maurizio Sessa
Journal:  Eur J Clin Pharmacol       Date:  2021-07-10       Impact factor: 2.953

8.  Invited Commentary on Stewart and Davis " 'Big data' in mental health research-current status and emerging possibilities".

Authors:  Jonathan D Hafferty; Daniel J Smith; Andrew M McIntosh
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-10-25       Impact factor: 4.519

9.  Correlation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reporting.

Authors:  Nora Anderson; Juergen Borlak
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

10.  Real-world impact of reminder packaging on antihypertensive treatment adherence and persistence.

Authors:  Leon Dupclay; Michael Eaddy; James Jackson; Aditya Raju; Andrew Shim
Journal:  Patient Prefer Adherence       Date:  2012-07-18       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.